These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1289674)

  • 41. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.
    Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N
    Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.
    Story MT; Hopp KA; Molter M
    J Cell Physiol; 1996 Oct; 169(1):97-107. PubMed ID: 8841426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.
    Barrack ER
    Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
    Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
    Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of beta radiation on TGF-beta1 and bFGF expression in hyperplastic prostatic tissues.
    Ma QJ; Gu XQ; Cao X; Zhao J; Kong XB; Li YX; Cai SY
    Asian J Androl; 2005 Mar; 7(1):49-54. PubMed ID: 15685352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.
    Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
    Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
    Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
    Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
    Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
    Steiner MS; Barrack ER
    Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Lang S; Kato M; Oefelein MG; Miyazono K; Nemeth JA; Kozlowski JM; Lee C
    Clin Cancer Res; 1996 Aug; 2(8):1255-61. PubMed ID: 9816295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
    Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
    Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
    Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
    Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer.
    Knabbe C; Klein H; Zugmaier G; Voigt KD
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):137-42. PubMed ID: 8274428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.